Literature DB >> 25056132

Population study of disease burden, management, and treatment of bipolar disorder in Sweden: a retrospective observational registry study.

Andreas Carlborg1, Lena Ferntoft, Marcus Thuresson, Johan Bodegard.   

Abstract

OBJECTIVES: The aim of the study was to describe temporal changes in bipolar disorder during 20 years within the Swedish population and to investigate clinical and socioeconomic characteristics, drug treatment, and mortality among patients with bipolar disorder.
METHODS: We conducted a retrospective, nationwide registry study (the Swedish Population Register) that included all patients diagnosed with bipolar disorder (1991-2010) and linked individual data from the Swedish National Patient Register, the National Prescribed Drug Register, and the Population Register (NCT01455961). A cross-sectional cohort analysis was performed for years 2006 versus 2009. Data were analyzed using descriptive statistics.
RESULTS: During the study period, the annual incidence of diagnosed bipolar disorder increased 3.5-fold, and patients were diagnosed at a younger age. Mortality among patients with bipolar disorder was twice that of the general population. Compared to an age-standardized population, 30% fewer patients with bipolar disorder were available for work. Among the 40% employed, 64% reported sick leave (46% >100 days/year). Despite similar education levels, disposable income was lower compared to the general population. The most commonly preceding psychiatric diagnoses were depressive or anxiety disorders. Comparing the data for 2006 and 2009 demonstrated similar somatic comorbidity burdens and socioeconomic levels. There was also a decrease in dispensed antipsychotic medications and lithium, while antiepileptic prescriptions increased slightly. Antidepressant dispenses remained virtually unchanged.
CONCLUSIONS: In Sweden, the incidence and prevalence of diagnosed bipolar disorder have increased during the last 20 years. Compared to the general population, these patients had similar education levels, lower employment levels, less disposable income, more sick leave, and twice the mortality. A trend towards earlier diagnosis, more use of antidepressants, and less use of lithium was seen.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  bipolar disorder; incidence; mortality; prevalence; socioeconomic factors

Mesh:

Substances:

Year:  2014        PMID: 25056132     DOI: 10.1111/bdi.12234

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  17 in total

1.  Characteristics of bipolar disorder patients treated with immediate- and extended-release quetiapine in a real clinical setting: a longitudinal, cohort study of 1761 patients.

Authors:  Andreas Carlborg; Marcus Thuresson; Lena Ferntoft; Johan Bodegard
Journal:  Ther Adv Psychopharmacol       Date:  2015-02

2.  Cost-Effectiveness Evaluations of Psychological Therapies for Schizophrenia and Bipolar Disorder: A Systematic Review.

Authors:  Gemma Elizabeth Shields; Deborah Buck; Jamie Elvidge; Karen Petra Hayhurst; Linda Mary Davies
Journal:  Int J Technol Assess Health Care       Date:  2019-07-22       Impact factor: 2.188

Review 3.  Bipolar disorder in pregnancy and childbirth: a systematic review of outcomes.

Authors:  Marie Rusner; Marie Berg; Cecily Begley
Journal:  BMC Pregnancy Childbirth       Date:  2016-10-28       Impact factor: 3.007

Review 4.  Atypical Antipsychotics in the Treatment of Acute Bipolar Depression with Mixed Features: A Systematic Review and Exploratory Meta-Analysis of Placebo-Controlled Clinical Trials.

Authors:  Michele Fornaro; Brendon Stubbs; Domenico De Berardis; Giampaolo Perna; Alessandro Valchera; Nicola Veronese; Marco Solmi; Licínia Ganança
Journal:  Int J Mol Sci       Date:  2016-02-16       Impact factor: 5.923

Review 5.  Lithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations.

Authors:  Paolo Girardi; Roberto Brugnoli; Giovanni Manfredi; Gabriele Sani
Journal:  Drugs R D       Date:  2016-12

6.  Building a genetic risk model for bipolar disorder from genome-wide association data with random forest algorithm.

Authors:  Li-Chung Chuang; Po-Hsiu Kuo
Journal:  Sci Rep       Date:  2017-01-03       Impact factor: 4.379

7.  Social Aspects of the Workplace Among Individuals With Bipolar Disorder.

Authors:  Lisa O'Donnell; Joseph A Himle; Kelly Ryan; Andrew Grogan-Kaylor; Melvin G McInnis; Jenna Weintraub; Marisa Kelly; Patricia Deldin
Journal:  J Soc Social Work Res       Date:  2017-07-19

8.  Resilience Predicts Self-Stigma and Stigma Resistance in Stabilized Patients With Bipolar I Disorder.

Authors:  Fabienne Post; Melanie Buchta; Georg Kemmler; Silvia Pardeller; Beatrice Frajo-Apor; Alex Hofer
Journal:  Front Psychiatry       Date:  2021-05-21       Impact factor: 4.157

Review 9.  Big data for bipolar disorder.

Authors:  Scott Monteith; Tasha Glenn; John Geddes; Peter C Whybrow; Michael Bauer
Journal:  Int J Bipolar Disord       Date:  2016-04-11

10.  Management of bipolar disorder in the intercontinental region: an international, multicenter, non-interventional, cross-sectional study in real-life conditions.

Authors:  Ludovic Samalin; Eduard Vieta; Tarek Ahmed Okasha; Mm Jalal Uddin; Seyed Ali Ahmadi Abhari; Fethi Nacef; Vyacheslav Mishyiev; Dovi Aizenberg; Yaël Ratner; Lydie Melas-Melt; Idir Sedeki; Pierre Michel Llorca
Journal:  Sci Rep       Date:  2016-05-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.